Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Seagen, Inc. News

Genmab, Seagen, Lennar, SmileDirect See After-Hours Moves

Drug makers gain on accelerated FDA approval for a cervical cancer treatment.

Pieris Pharma Wavers After $13M Seagen Equity Investment

Pieris and Seagen have amended an ongoing collaboration which will have the latter give the former $13 million in an equity investment as the two work together to study a gastric cancer drug.

Buy-the-Dip Candidates in the Stock Market: Tesla, Palantir

These stocks that fell this past week could be 'buy the dip' opportunities. Recent losers include Seagen, Penn National, Palantir, Canopy Growth, Pepsi and more.

Bumble, Tilray, Disney, PepsiCo and Pinterest - 5 Things You Must Know Thursday

Stock futures rise as Wall Street debates tame inflation data; Bumble IPO raises $2.15 billion; Disney and Pepsi report earnings; Tilray surges again as cannabis sector is targeted by Reddit crowd.

5 Worst Stocks in the Nasdaq on Wednesday: Moderna Slides Again

The worst-performing stocks in the Nasdaq on Wednesday included Moderna, Seattle Genetics, and Facebook, among others.

Breaking News

The Good Times Are Over for Startups

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.